Skip to main content
Premium Trial:

Request an Annual Quote

Bristol-Myers Tests SAS Software for Gene Expression, Proteomics

NEW YORK, Jan. 14 (GenomeWeb News) - Bristol Myers-Squibb will test software from SAS to streamline its research processes and improve collaborations, SAS said today.

 

During a three-month pilot project, BMS scientists will use SAS Microarray Solution and SAS Research Data Management to co-develop statistical methods for analyzing their gene expression data. They also plan to use SAS Proteomics Solution to analyze mass spectrometry data.

 

SAS, based in Cary, N.C., plans to release SAS Proteomics Solution this year.

 

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.